Moreover, it emerges that PTH and alkaline phosphatase are monitored much more frequently than recommended by guidelines as they are considered of equal importance in the assessment of CKD-MBD and fracture risk. The gene discussed is PTH; the disease is Marchiafava-Bignami disease.